Coronary Artery Disease Clinical Trial
Official title:
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using Computed Tomography Coronary Angiogram (CTCA) Versus Traditional Care for Low- to Intermediate-Risk Emergency Department (ED) Patients With Potential Acute Coronary Syndromes (ACS)
NCT number | NCT00933400 |
Other study ID # | ACRIN PA 4005 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 2009 |
Est. completion date | April 2012 |
Verified date | February 2024 |
Source | American College of Radiology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This multi-center, randomized, controlled trial conducted in Emergency Departments (ED) compares computed tomography (CT) coronary angiography with the traditional approach (usual care) for low- to intermediate-risk chest pain patients. The primary objective is to estimate the rate of major cardiac events (heart attack or cardiac death) within 30 days in trial participants in Group B who were not found to have significant coronary artery disease by CT coronary angiography. Additional evaluations will comprise health care utilization assessments, including length of hospital stay and re-admissions, cost analysis, and 1-year post-triage/presentation major cardiac event rates.
Status | Completed |
Enrollment | 1392 |
Est. completion date | April 2012 |
Est. primary completion date | February 2012 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years and older |
Eligibility | Inclusion Criteria: - Participant is 30 years of age or older - Participant presents with complaints consistent with potential ACS (e.g., chest pain, shortness of breath, other) - Participant requires admission or objective testing to exclude ACS - Participant with initial ECG result without acute ischemia - Participant with an initial Thrombolysis in Myocardial Infarction (TIMI) Risk Score of 0 to 2 - Participant is willing to provide a written informed consent Exclusion Criteria: - Patients who present with symptoms that are clearly not cardiac in origin (e.g., chest pain secondary to herpes zoster, obvious pneumonia, or recent trauma); - Patients with no initial ECG performed in the ED - Patients with ST-elevation myocardial infarction (STEMI) - Patients with existing co-morbidity that requires admission regardless of presence of ACS (e.g., uncontrolled diabetes) - Patients with known contraindications to CT coronary angiography: Iodinated contrast allergic-like reaction - Patients who are known to have had CT coronary angiography in the year prior to presentation - Patients who are known to have normal catheterization results (no or minimal, < 25%, stenosis) in the year prior to presentation - Patients who are pregnant - Patients with known renal insufficiency (e.g., creatinine clearance < 60 mL/min/1.73 m2) - Patients with no telephone or cell phone numbers (preventing follow up) - Patients unwilling to provide a written informed consent |
Country | Name | City | State |
---|---|---|---|
United States | Penn State Hershey - Milton S. Hershey Medical Center | Hershey | Pennsylvania |
United States | Penn-Presbyterian Medical Center | Philadelphia | Pennsylvania |
United States | University of Pennsylvania Health System | Philadelphia | Pennsylvania |
United States | University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania |
United States | Wake Forest University Baptist Medical Center | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
American College of Radiology | Pennsylvania Department of Health |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rates of Major Cardiac Events (AMI or Cardiac Death) Within 30 Days | To estimate the rate of major cardiac events (AMI or cardiac death) within 30 days of discharge from Emergency Department (ED) - patient follow-up included telephone interviews 30 days and 1 year after triage/presentation.
Participants in Group B who were found not to have stenosis of the main or first order coronary branches greater than or equal to 50% by CT coronary angiography were considered negative and considered discharged if they were not designated to receive an inpatient bed or formal observation status. All myocardial infarctions were reviewed by an Adjudication Committee to confirm diagnosis. |
up to 30 days of discharge from the ED | |
Secondary | Significant Coronary Artery Disease Detected Within Index Hospitalization as Assessed by Medical Record Review. | The algorithm used for diagnosis of Significant coronary artery disease is provided in the Appendix of the protocol. | baseline | |
Secondary | Mean Length of Hospital Stay After Initial Visit | Compare the length of hospital stay in hours between the groups | 1-7 days | |
Secondary | Health Care Utilization During the Index Hospitalization. | Downstream diagnostic test during the index visit including Hospital admission or observation. | 1-7 Days | |
Secondary | Cardiac Health Care Utilization 1 Year Post Triage/Presentation. | Through 1-yr study follow up | ||
Secondary | Major Adverse Cardiac Event (MACE, Including Myocardial Infarction & Cardiac Death) and Revascularization for Participants Within 1 Year Post Triage/Presentation | MACE at 1 year was determined by Patient telephone contact Medical record review Records at the presenting and neighboring hospitals were reviewed for repeat visits When these methods failed to provide survival information, we searched the Social Security Death Master File | Through 1-yr study follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |